BioWorld-International-2003-04-09
Serono Signs On Graffinity As Partner For Drug Development
Serono Signs On Graffinity As Partner For Drug Development
Graffinity AG, a specialist in preclinical drug discovery, landed a commitment from Serono SA to help fill the development pipeline of Europe's largest biotechnology company. (BioWorld International)

